Literature DB >> 2662036

Veno-occlusive hepatic disease of the liver in renal transplantation: is azathioprine the cause?

F Liaño1, A Moreno, R Matesanz, J L Teruel, C Redondo, F García-Martín, L Orte, J Ortuño.   

Abstract

Five male patients with veno-occlusive disease of the liver (VOD) were observed in 200 consecutive renal transplants (RT) treated with azathioprine and prednisone. Mild liver enzymatic increases not justified by other reasons were detected between 2 and 9 months after RT. All 5 patients developed portal hypertension and died between 18 and 79 months following RT. Diagnosis of VOD was histological; in 3 cases diagnosis was made while the patients were still alive. In our patients, 9 previous viral hepatotropic infections (5 during hemodialysis and 4 after TR) were demonstrated. Due to the reported low incidence of VOD in RT patients, when many of them have been treated with azathioprine, the etiological role of this drug must be questioned. However, the possible association of a previous hepatotropic viral infection and the use of an immunosuppressive agent should be considered as a probable cause of VOD in kidney grafts.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2662036     DOI: 10.1159/000185385

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Veno-occlusive disease (VOD) in Crohn's disease (CD) treated with azathioprine.

Authors:  M Holtmann; O Schreiner; H Köhler; U Denzer; M Neurath; P R Galle; T Höhler
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

2.  Venoocclusive disease of the liver following renal transplantation.

Authors:  M A Jeffries; W M McDonnell; J A Tworek; R M Merion; R H Moseley
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

Review 3.  Fibrosing cholestatic hepatitis in renal transplant recipient with CMV infection: a case report.

Authors:  S K Agarwal; V Kalra; Amit Dinda; S Gupta; S C Dash; D Bhowmik; S C Tiwari
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

4.  Idiopathic portal hypertension in a renal transplant patient after long-term azathioprine therapy.

Authors:  R Lorenz; M Brauer; M Classen; N Tornieporth; K Becker
Journal:  Clin Investig       Date:  1992-02

5.  Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation.

Authors:  O Pappo; H Ramos; T E Starzl; J J Fung; A J Demetris
Journal:  Am J Surg Pathol       Date:  1995-02       Impact factor: 6.394

6.  In vitro grafting of hepatic spheroids and organoids on a microfluidic vascular bed.

Authors:  Flavio Bonanini; Dorota Kurek; Sara Previdi; Arnaud Nicolas; Delilah Hendriks; Sander de Ruiter; Marine Meyer; Maria Clapés Cabrer; Roelof Dinkelberg; Silvia Bonilla García; Bart Kramer; Thomas Olivier; Huili Hu; Carmen López-Iglesias; Frederik Schavemaker; Erik Walinga; Devanjali Dutta; Karla Queiroz; Karel Domansky; Bob Ronden; Jos Joore; Henriette L Lanz; Peter J Peters; Sebastiaan J Trietsch; Hans Clevers; Paul Vulto
Journal:  Angiogenesis       Date:  2022-06-15       Impact factor: 10.658

Review 7.  Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.

Authors:  Yuchen Hou; Nga Lei Tam; Zhicheng Xue; Xuzhi Zhang; Bing Liao; Jie Yang; Shunjun Fu; Yi Ma; Linwei Wu; Xiaoshun He
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.